STEMCELL Technologies, Canada’s leading biotechnology company, has acquired Cellular Highways Ltd, a UK-based biotech company specializing in advanced cell sorting technologies for cell and gene therapy, drug discovery, and general cell research. The acquisition includes the innovative Highway1 instrument, featuring Cellular Highways’ VACS™ technology, which enhances cell processing efficiency and maintains high cell integrity, reducing timelines and costs for research and development. This strategic move by STEMCELL Technologies expands their capabilities in cell manufacturing and positions them as a key player in the evolving biotech landscape. The acquisition of Cellular Highways’ expertise and technology signifies a significant advancement in the field of cell therapy, offering researchers new tools and solutions to accelerate progress in cell-based research and therapeutic development.By integrating Cellular Highways’ cutting-edge technologies into their portfolio, STEMCELL Technologies strengthens their position as an industry leader in advancing cell manufacturing processes. The Highway1 instrument, powered by VACS™ technology, opens up new possibilities for researchers and cell therapy developers to optimize their workflows and enhance the integrity of delicate cell applications. This acquisition not only streamlines research and development efforts but also paves the way for future innovations in the field of cell and gene therapy. With a focus on maximizing efficiency and maintaining cell quality, STEMCELL Technologies and Cellular Highways are poised to drive significant advancements in the biotechnology sector, ultimately benefiting patients and researchers alike. The collaboration between these two innovative companies sets a new standard for the integration of cutting-edge technologies in the pursuit of advancements in cell-based therapies and research.
Learn more about cell manufacturing.
Read more from businesswire.com
